Trademark: 79295832
Word
14 SI
Status
Registered
Status Code
700
Status Date
Tuesday, April 26, 2022
Serial Number
79295832
Registration Number
6708925
Registration Date
Tuesday, April 26, 2022
Mark Type
3
Filing Date
Friday, June 5, 2020
Published for Opposition
Tuesday, February 8, 2022

Trademark Owner History
Veritas In Silico Inc. - Original Registrant

Classifications
41 Educational and instruction services, namely, organizing events for educational and teaching purposes relating to arts, crafts, sports and general knowledge; teaching in the field of drug discovery and development; educating at universities and graduate schools; arranging, conducting and organization of seminars; arranging, conducting and organization of symposiums, lecture meetings, workshops and study groups; arranging, conducting and organization of educational seminars, symposiums, lecture meetings, workshops and study groups in the field of drug discovery and development; providing online non-downloadable electronic publications in the nature of magazines, newsletters, journals and books in the field of nucleic acids, pharmaceuticals, drug discovery and development, medicine, chemicals and engineering; reference libraries of literature and documentary records; book rental; providing online music, sound recordings, videos featuring information and instruction on nucleic acids, pharmaceuticals, drug discovery and development, medicine, chemicals and engineering, images and character text information, non-downloadable; educational services in the nature of providing exhibits of academic materials in the field of nucleic acids, pharmaceuticals, drug discovery and development, medicine, chemicals and engineering; art exhibitions; publication of books; movie theatre presentations, namely, movie showing and movie film production and distribution; production of videotape film in the field of education, culture, entertainment or sports, not for movies or television programs and not for advertising or publicity
42 Designing of machines, apparatus, instruments, including their parts, or systems composed of such machines, apparatus and instruments; pharmaceutical, medicine and chemical industrial design services for use in medicines and engineering design services, not for advertising; computer software design, computer programming, and maintenance of computer software; designing, programming and maintenance of computer software having artificial intelligence functionality; computer software design, computer programming, and maintenance of computer software for use in scientific and technical analysis of data from artificial intelligence; computer software design, computer programming, and maintenance of computer software for use in analysis, testing, screening, designing, development or research on nucleic acids, pharmaceuticals or chemicals; computer software design, computer programming, and maintenance of computer software for use in drug discovery screening; computer software design, computer programming, and maintenance of computer software for use in genome research or the development of consumer health products, treatments, pharmaceutical preparations, diagnostic instruments or foodstuffs; data conversion of electronic information using computers technological advice relating to computers, automobiles and other industrial machines requiring highly specialized knowledge, skills and experiences for proper operation, namely, computer technology consultancy, automobile transmission diagnostic consulting and industrial machine part design consulting; scientific research, testing and analysis in the field of nucleic acids, pharmaceuticals, drug discovery and development, medicines, chemicals and engineering; quality control assessment services for others; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; testing, inspection or research of chemicals or reagents; providing information and consultancy on testing, inspection or research of pharmaceuticals, chemicals, reagents, cosmetics or foodstuffs; scientific or laboratory testing, inspection or research of nucleic acids, chemicals and pharmaceuticals for drug development and medical research purposes, and providing scientific information and research consultancy relating thereto; testing or scientific research on biotechnology and providing scientific information and research consultancy relating thereto; genomic experiments, analyses, research, assays, tests, inspection, detection or verification, namely, scientific genomic analyses, scientific genomic research, custom design and development of biochemical genomic assays, genome amplification and functional and structural analysis of genomes; scientific research consultancy, advice and providing information in the field of genomic experiments, analyses, research, assays, tests, inspection, detection or verification; scientific and technological services, namely, testing, analysis surveying, research or data analysis in the field of biomedicine, genome biology, pharmacogenomics, diagnostics, clinical trials and bioengineering; research and development of vaccines and medicines; development of pharmaceutical preparations and medicines; conducting clinical trials for pharmaceuticals for others; research on building construction or city planning; testing or research on prevention of pollution; testing or research on electricity; testing or research on civil engineering; testing, inspection or research on agriculture, livestock breeding or fisheries; testing or research on machines, apparatus and instruments, namely, testing the functionality of machines, research on machines and technology research in the field of medical instruments and drug manufacturing machines; rental of measuring apparatus; rental of computers; providing computer programs on data networks, namely, providing temporary use of non-downloadable computer software for enabling, supporting and accelerating processes of RNA-targeted drug discovery and development for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; cloud computing, namely, providing temporary use of on-line non-downloadable cloud computing software for enabling, supporting and accelerating processes of RNA-targeted drug discovery and development for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; software as a service (SaaS) services featuring software for enabling, supporting and accelerating processes of RNA-targeted drug discovery and development for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; electronic storage services for archiving electronic data; cloud server storage services on the internet for electronic files; providing temporary use of non-downloadable computer software having artificial intelligence functionality on data networks for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; providing online non-downloadable computer software for analysis of science and technology data based on artificial intelligence (AI) technology; providing online non-downloadable computer software for analyzing, testing, screening, designing, development and research of nucleic acids, pharmaceuticals and chemicals; providing online non-downloadable computer software for drug discovery screening; providing online non-downloadable computer software for genome research and development research of consumer health products, treatments, pharmaceutical preparations, diagnostic instruments and foodstuffs; rental of laboratory apparatus and instruments
The mark consists of the numerals "14" and the letters "SI" in black within a red square.
ONE FOUR SI; FOURTEEN SI
The color(s) black and red is/are claimed as a feature of the mark.

Trademark Events
Oct 15, 2020
Sn Assigned For Sect 66a Appl From Ib
Oct 19, 2020
New Application Office Supplied Data Entered
Oct 19, 2020
Assigned To Examiner
Oct 23, 2020
Application Filing Receipt Mailed
May 10, 2021
Teas Response To Office Action Received
Oct 26, 2020
Non-Final Action Written
Oct 27, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Nov 17, 2020
Refusal Processed By Mpu
Nov 17, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Dec 7, 2020
Refusal Processed By Ib
May 10, 2021
Correspondence Received In Law Office
May 10, 2021
Teas/Email Correspondence Entered
Jun 11, 2021
Final Refusal Written
Jun 11, 2021
Final Refusal E-Mailed
Jun 11, 2021
Notification Of Final Refusal Emailed
Nov 30, 2021
Teas Request For Reconsideration Received
Nov 30, 2021
Correspondence Received In Law Office
Nov 30, 2021
Teas/Email Correspondence Entered
Jan 3, 2022
Approved For Pub - Principal Register
Jan 4, 2022
Assigned To Lie
Jan 5, 2022
Law Office Publication Review Completed
Jan 19, 2022
Notification Of Notice Of Publication E-Mailed
Jan 19, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 19, 2022
Notification Of Possible Opposition Sent To Ib
Feb 8, 2022
Published For Opposition
Mar 7, 2022
Assigned To Examiner
Feb 8, 2022
Official Gazette Publication Confirmation E-Mailed
Feb 14, 2022
Notification Processed By Ib
Mar 16, 2022
Notification Of Possible Opposition Sent To Ib
Mar 16, 2022
Notification Of Possible Opposition Created, To Be Sent To Ib
Aug 31, 2022
Final Disposition Processed
Apr 4, 2022
Notification Of Possible Opposition - Processed By Ib
Apr 26, 2022
Registered-Principal Register
Jul 26, 2022
Final Disposition Notice Created, To Be Sent To Ib
Oct 11, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 11, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 11, 2022
Teas Change Of Domestic Representatives Address
Oct 11, 2022
Teas Change Of Correspondence Received
Aug 20, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 20, 2024
Teas Change Of Correspondence Received
Aug 20, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 20, 2024
Teas Withdrawal Of Attorney Received-Firm Retains
Sep 20, 2022
Final Decision Transaction Processed By Ib
Aug 31, 2022
Final Disposition Notice Sent To Ib

Trademark Alertz updated from USPTO on 2030-01-24